Trial intelligence / Profile preview

Tranexamic Acid in Hip Fracture

NCT05489185Phase 4Unknown

Sponsor
Biogipuzkoa Health Research Institute
Start
May 2023
Primary completion
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tranexamic acid in hip fracture, sponsored by Biogipuzkoa Health Research Institute. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

hip fracture

Beyond the preview

Go deeper on NCT05489185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05489185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call